| Financier | Commitments |
|---|---|
| International Bank for Reconstruction and Development | 1000.00 |
India COVID-19 Emergency Response and Health Systems Preparedness Project
Abstract*
tbc Show More
Development Objective
The proposed project development objective is to prevent, detect and respond to the threat posed by COVID-19 and strengthen national health systems for preparedness in India.
Key Details
Project Details
P173836
Closed
Dinesh Nair , Suresh Mohammed
Republic of India, Ministry of Finance
March 23, 2020
(as of board presentation)
April 2, 2020
April 6, 2020
US$ 500.00 million
Ministry of Health and Family Welfare
2020
US$ 1000.00 million
N/A
September 20, 2023
March 31, 2023
No
BANK APPROVED
Finances
Financing Plan (US$ Millions)
Total Project Financing (US$ Millions)
| Product Line | IBRD/IDA |
|---|---|
| IBRD Commitment | 1000.00 |
| IDA Commitment | N/A |
| IBRD + IDA Commitment | 1000.00 |
| Lending Instrument | |
|---|---|
| Grant Amount | N/A |
| Total Project Cost** | 500.00 |
Summary Status of World Bank Financing (US$ Millions) as of February 28, 2025
No data available.
| Period | Financier | Transaction Type | Amount (US$) |
|---|---|---|---|
| Sep 15, 2023 | IBRD-90860 | Int Charges | 21,889,620.00 |
| Sep 15, 2023 | IBRD-90860 | Int Charges | 346,074.72 |
| Sep 15, 2023 | IBRD-90860 | Int Charges | 3,705.14 |
| Sep 15, 2023 | IBRD-90860 | Int Charges | 7,296,540.00 |
| Sep 15, 2023 | IBRD-90860 | Int Charges | 95,484.38 |
| Sep 15, 2022 | IBRD-90860 | Int Charges | 2,885.72 |
| Sep 15, 2022 | IBRD-90860 | Int Charges | 1,123.33 |
| Sep 15, 2022 | IBRD-90860 | Int Charges | 6,470,428.00 |
| Sep 15, 2022 | IBRD-90860 | Int Charges | 2,346,269.80 |
| Sep 15, 2022 | IBRD-90860 | Int Charges | 76,823.70 |
| Mar 15, 2023 | IBRD-90860 | Int Charges | 786,888.60 |
| Mar 15, 2023 | IBRD-90860 | Int Charges | 6,162,507.50 |
| Mar 15, 2023 | IBRD-90860 | Int Charges | 6,307,466.50 |
| Mar 15, 2023 | IBRD-90860 | Int Charges | 285,148.97 |
| Mar 15, 2023 | IBRD-90860 | Int Charges | 70,809.33 |
| Mar 15, 2023 | IBRD-90860 | Int Charges | 1,844,607.60 |
| Mar 15, 2023 | IBRD-90860 | Int Charges | 9,398,828.00 |
| Mar 15, 2022 | IBRD-90860 | Int Charges | 24,053.73 |
| Mar 15, 2022 | IBRD-90860 | Int Charges | 202,587.05 |
| Mar 15, 2022 | IBRD-90860 | Int Charges | 2,591,313.50 |
| Mar 15, 2022 | IBRD-90860 | Int Charges | 1,106,111.10 |
| Mar 15, 2022 | IBRD-90860 | Int Charges | 8,940.06 |
| Feb 28, 2022 | IBRD-90860 | Loan Disb | 10,933,784.00 |
| Dec 21, 2021 | IBRD-90860 | Loan Disb | 3,793,598.80 |
| Dec 23, 2021 | IBRD-90860 | Loan Disb | 42,875,024.00 |
| Dec 23, 2021 | IBRD-90860 | Loan Disb | 17,093,438.00 |
| Aug 26, 2021 | IBRD-90860 | Loan Disb | 10,359,244.00 |
| Aug 26, 2021 | IBRD-90860 | Loan Disb | 19,221,216.00 |
| Aug 26, 2021 | IBRD-90860 | Loan Disb | 12,662,638.00 |
| Sep 17, 2021 | IBRD-90860 | Loan Disb | 23,586,704.00 |
| Sep 17, 2021 | IBRD-90860 | Loan Disb | 912,396.25 |
| Aug 25, 2021 | IBRD-90860 | Loan Disb | 1,268,602.90 |
| Aug 25, 2021 | IBRD-90860 | Loan Disb | 3,623,501.80 |
| Oct 28, 2021 | IBRD-90860 | Loan Disb | 23,468,942.00 |
| Sep 15, 2021 | IBRD-90860 | Int Charges | 1,297,652.20 |
| Sep 15, 2021 | IBRD-90860 | Int Charges | 1,162,777.80 |
| Sep 15, 2021 | IBRD-90860 | Int Charges | 29,049.30 |
| Sep 15, 2021 | IBRD-90860 | Int Charges | 217,063.06 |
| Apr 2, 2020 | IBRD-90860 | Loan Commitment | 750,000,000.00 |
| Apr 2, 2020 | IBRD-90860 | Loan Commitment | 250,000,000.00 |
| Mar 15, 2024 | IBRD-90860 | Int Charges | 384,806.28 |
| Mar 15, 2024 | IBRD-90860 | Int Charges | 128,268.77 |
| Mar 15, 2024 | IBRD-90860 | Int Charges | 10,688,242.00 |
| Mar 15, 2024 | IBRD-90860 | Int Charges | 8,102,850.00 |
| Mar 15, 2024 | IBRD-90860 | Int Charges | 13,620,309.00 |
| Mar 6, 2023 | IBRD-90860 | Loan Disb | 60,105,592.00 |
| Sep 15, 2021 | IBRD-90860 | Int Charges | 467,921.90 |
| Mar 18, 2022 | IBRD-90860 | Loan Disb | 52,276,720.00 |
| Jun 18, 2021 | IBRD-90860 | Loan Disb | 135,103,088.00 |
| Jul 13, 2021 | IBRD-90860 | Loan Disb | 2,672,600.00 |
| May 10, 2021 | IBRD-90860 | Loan Disb | 4,830,000.00 |
| Jun 28, 2021 | IBRD-90860 | Loan Disb | 2,737,000.00 |
| Apr 12, 2021 | IBRD-90860 | Loan Disb | 25,790,676.00 |
| Jul 16, 2021 | IBRD-90860 | Loan Disb | 5,863,160.00 |
| Sep 30, 2021 | IBRD-90860 | Loan Disb | 3,898,936.20 |
| Apr 9, 2020 | IBRD-90860 | Loan Disb | 200,000,000.00 |
| Apr 6, 2020 | IBRD-90860 | Loan Disb | 1,875,000.00 |
| Apr 6, 2020 | IBRD-90860 | Fee Charges | 1,875,000.00 |
| Apr 6, 2020 | IBRD-90860 | Loan Disb | 625,000.00 |
| Apr 6, 2020 | IBRD-90860 | Fee Charges | 625,000.00 |
| May 5, 2020 | IBRD-90860 | Loan Disb | 250,624,992.00 |
| May 5, 2020 | IBRD-90860 | Loan Disb | 49,375,000.00 |
| Feb 12, 2021 | IBRD-90860 | Loan Disb | 16,378,525.00 |
| Feb 12, 2021 | IBRD-90860 | Loan Disb | 18,044,612.00 |
| Sep 15, 2020 | IBRD-90860 | Int Charges | 1,663,156.60 |
| Sep 15, 2020 | IBRD-90860 | Int Charges | 1,902,035.10 |
| Mar 15, 2021 | IBRD-90860 | Int Charges | 1,244,123.60 |
| Mar 15, 2021 | IBRD-90860 | Int Charges | 1,231,805.50 |
Ratings
IMPLEMENTATION RATINGS
| Name | Review | Date |
|---|---|---|
| Financial Management | Moderately Satisfactory | 2023-06-20 |
| Progress towards achievement of PDO | Satisfactory | 2023-06-20 |
| Procurement | Satisfactory | 2023-06-20 |
| Project Management | Satisfactory | 2023-06-20 |
| Monitoring and Evaluation | Satisfactory | 2023-06-20 |
| Overall Implementation Progress (IP) | Satisfactory | 2023-06-20 |
COMPLETION RATINGS
No data available.
INDEPENDENT EVALUATION RATINGS
No data available.
Results Framework
PROJECT DEVELOPMENT OBJECTIVE INDICATORS
| INDICATOR | BASELINE | CURRENT | TARGET |
|---|
Percentage of district hospitals with isolation capacity Value 0.00 100.00 70.00 Date March 20, 2020 March 31, 2023 March 31, 2023 Comment Proportion of specimens submitted for COVID-19 laboratory testing confirmed within WHO-stipulated standard time Value 0.00 96.00 70.00 Date March 20, 2020 March 31, 2023 March 31, 2023 Comment Proportion of population able to identify three key symptoms of COVID-19 and/or seasonal influenza and three personal prevention measures (as assessed by a representative population survey) Value 0.00 79.00 50.00 Date March 20, 2020 March 31, 2021 March 31, 2023 Comment The Government has activated their one health coordination mechanism for COVID-19 Value No Yes Yes Date March 20, 2020 March 31, 2023 March 31, 2023 Comment Percentage of district health centers/district hospitals with personal protective equipment and infection control products and supplies, without stock-outs in preceding two weeks Value 0.00 100.00 70.00 Date March 20, 2020 March 31, 2023 March 31, 2023 Comment Percentage of States with at least 80 percent of districts having dedicated core surveillance staff in the District Surveillance Unit in position. Value 28.00 39.00 50.00 Date May 21, 2020 March 31, 2023 March 31, 2023 Comment
INTERMEDIATE RESULTS INDICATORS
| INDICATOR | BASELINE | CURRENT | TARGET |
|---|
Proportion of states with Emerging Infectious Disease Contingency Plans in place with dedicated budget Value 0.00 94.45 70.00 Date March 20, 2020 March 31, 2023 March 31, 2023 Comment Proportion of states using a national health information reporting platform that unifies multiple pre-existing platforms. Value 0.00 100.00 70.00 Date March 20, 2020 March 31, 2023 March 31, 2023 Comment Proportion of COVID-19 grievances received and redressed within government’s stipulated timeline Value 0.00 99.00 80.00 Date March 31, 2020 March 31, 2023 March 31, 2023 Comment Proportion of outbreaks where human samples were collected and sent to laboratory for confirmation Value 19.00 71.00 65.00 Date May 21, 2020 March 31, 2023 March 31, 2023 Comment No. of tests per million per day (in concordance with WHO stipulated standard of 140 tests per million per day) (%) Value 0.00 555.00 140.00 Date March 20, 2020 March 31, 2023 March 31, 2023 Comment % of Real Time Polymerase Chain Reaction (RT-PCR) designated laboratories meeting external quality control standards (reflects laboratory system quality, using COVID19 testing as a proxy) Value 100.00 80.60 100.00 Date March 20, 2020 March 31, 2023 March 31, 2023 Comment Proportion of states with sufficient COVID-19 testing capacity within 4 weeks of project implementation Value 0.00 100.00 70.00 Date March 20, 2020 December 31, 2021 March 31, 2023 Comment Proportion of states issuing school closures with state-level distance learning strategies for primary and secondary school students. Value 0.00 100.00 70.00 Date March 20, 2020 March 31, 2021 March 31, 2023 Comment Number of peer-reviewed publications produced with support of the project funding Value 0.00 346.00 40.00 Date March 20, 2020 March 31, 2023 March 31, 2023 Comment Number of district hospital doctors and nurses who are trained on WHO standards of clinical treatment for COVID-19 by March 2021 Value 0.00 142350.00 110000.00 Date March 20, 2020 March 31, 2021 March 31, 2023 Comment